Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,747,200 shares, an increase of 151.7% from the July 15th total of 694,202 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Ascentage Pharma Group International Stock Performance
OTCMKTS:ASPHF opened at $4.53 on Friday. Ascentage Pharma Group International has a 52-week low of $4.53 and a 52-week high of $5.05. The stock’s 50 day moving average price is $4.53 and its 200 day moving average price is $6.71.
About Ascentage Pharma Group International
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
